Huipusen Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Public

  • Employees
  • 221

Employees

  • Stock Symbol
  • CPHI

Stock Symbol

  • Share Price
  • $0.52
  • (As of Friday Closing)

Huipusen General Information

Description

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Contact Information

Website
www.helpson.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Number 17, Jinpan Road
  • Haikou, Hainan 570216
  • China
+86 0898
Primary Industry
Pharmaceuticals
Stock Exchange
ASE
Vertical(s)
Manufacturing
Corporate Office
  • Number 17, Jinpan Road
  • Haikou, Hainan 570216
  • China
+86 0898

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Huipusen Stock Performance

As of 13-Nov-2026, Huipusen’s stock price is $0.52. Its current market cap is $22.3M with 43M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.52 $0.56 $0.38 - $19.19 $22.3M 43M 1.6M -$0.42

Huipusen Financials Summary

As of 30-Jun-2026, Huipusen has a trailing 12-month revenue of $3.91M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 30,436 9,377 7,768 8,011
Revenue 3,914 4,144 4,529 7,011
EBITDA (1,324) (1,508) (1,912) 2
Net Income (4,475) (3,188) (4,736) (3,079)
Total Assets 44,710 30,999 14,888 16,469
Total Debt 4,056 3,887 3,745 4,634
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Huipusen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Huipusen‘s full profile, request access.

Request a free trial

Huipusen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and mark
Pharmaceuticals
Haikou, China
221 As of 2025

Denver, CO
 

Ahmedabad, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Huipusen Competitors (29)

One of Huipusen’s 29 competitors is Aytu Biopharma, a Corporation company based in Denver, CO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aytu Biopharma Corporation Denver, CO
Zydus Lifesciences Corporation Ahmedabad, India
Glenmark Pharmaceuticals Corporation Mumbai, India
Dr. Reddy's Corporation Hyderabad, India
Intas Pharmaceuticals Private Equity-Backed Ahmedabad, India
You’re viewing 5 of 29 competitors. Get the full list »

Huipusen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Huipusen ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Huipusen’s complete esg history, request access »

Huipusen FAQs

  • When was Huipusen founded?

    Huipusen was founded in 1993.

  • Where is Huipusen headquartered?

    Huipusen is headquartered in Haikou, China.

  • What is the size of Huipusen?

    Huipusen has 221 total employees.

  • What industry is Huipusen in?

    Huipusen’s primary industry is Pharmaceuticals.

  • Is Huipusen a private or public company?

    Huipusen is a Public company.

  • What is Huipusen’s stock symbol?

    The ticker symbol for Huipusen is CPHI.

  • What is the current stock price of Huipusen?

    As of 13-Nov-2026 the stock price of Huipusen is $0.52.

  • What is the current market cap of Huipusen?

    The current market capitalization of Huipusen is $22.3M.

  • What is Huipusen’s current revenue?

    The trailing twelve month revenue for Huipusen is $3.91M.

  • Who are Huipusen’s competitors?

    Aytu Biopharma, Zydus Lifesciences, Glenmark Pharmaceuticals, Dr. Reddy's, and Intas Pharmaceuticals are some of the 29 competitors of Huipusen.

  • What is Huipusen’s annual earnings per share (EPS)?

    Huipusen’s EPS for 12 months was -$0.42.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process